@article{dcd6efeab8c645c7967ca0b515cd6778,
title = "#SoMe for #IC: Optimal use of social media in interventional cardiology",
abstract = "Social media allows interventional cardiologists to disseminate and discuss research and clinical cases in real-time, to demonstrate and learn innovative techniques, to build professional networks, and to reach out to patients and the general public. Social media provides a democratic platform for all participants to influence the conversation and demonstrate their expertise. This review addresses the use of social media for these purposes in interventional cardiology, as well as respect for patient privacy, how to get started on social media, the creation of high-impact social media content, and the role of traditional journals in the age of social media. In the future, we hope that interventional cardiology fellowship programs will incorporate social media training into their curricula. In addition, professional societies may adapt to the rapid dissemination of data on social media by developing processes to update guidelines more rapidly and more frequently.",
keywords = "appropriate use, clinical trials, comparative effectiveness/patient centered outcomes research, evidence-based medicine, health care policy, new devices",
author = "Goldsweig, {Andrew M.} and Galper, {Benjamin Z.} and Chadi Alraies and Arnold, {Suzanne V.} and Matthew Daniels and Davide Capodanno and Giuseppe Tarantini and Cohen, {David J.} and Aronow, {Herbert D.}",
note = "Funding Information: Dr. Cohen reports research grant support from Abbott, Edwards Life Sciences, Boston Scientific, Medtronic, Svelte, and Corvia; consulting income from Abbott, Edwards Life Sciences, Boston Scientific, Medtronic, Svelte, Corvia, Philips, Impulse Dynamics, and MyoKardia. Dr. Goldsweig reports grant support from the National Institute of General Medical Sciences, 1U54GM115458, and the UNMC Center for Heart and Vascular Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. None of the other authors has any conflicts of interest to disclose. Funding Information: Dr. Cohen reports research grant support from Abbott, Edwards Life Sciences, Boston Scientific, Medtronic, Svelte, and Corvia; consulting income from Abbott, Edwards Life Sciences, Boston Scientific, Medtronic, Svelte, Corvia, Philips, Impulse Dynamics, and MyoKardia. Dr. Goldsweig reports grant support from the National Institute of General Medical Sciences, 1U54GM115458, and the UNMC Center for Heart and Vascular Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. None of the other authors has any conflicts of interest to disclose. Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC.",
year = "2021",
month = jul,
day = "1",
doi = "10.1002/ccd.29643",
language = "English (US)",
volume = "98",
pages = "97--106",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",
number = "1",
}